Ria Kakkad (Drug Target Review)2023-01-11T11:21:09
The researchers used single-nuclear sequencing and advanced three-dimensional glass imaging of mice to find new drug targets for non-alcoholic fatty liver disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-10-21T15:00:00
Sponsored by Oxford Nanopore Technologies
2026-09-30T13:00:00
Sponsored by Sartorius
2026-09-03T07:00:00
Contributor Marty Parrish and Steve Hoffmann, Drug Target Review
2024-05-10T11:23:31
Sponsored by BellBrook Labs
2026-09-24T06:30:00
Contributor Dr Dan Benjamin, Drug Target Review
Site powered by Webvision Cloud